We are proud to announce that the first ophthalmic gene therapy in Switzerland has been performed in the Eye Clinic of the University Hospital Basel.
The gene therapy is available for patients with Leber congenital amaurosis and retinitis pigmentosa caused by mutations in the RPE65 gene – one out of 280 known disease genes that can cause retinal dystrophies.
To learn more about the disease and the therapy, you can watch the interview of Prof. Scholl here (only in German).
To watch the story about the patient who has received the first ophthalmic gene therapy in Switzerland delivered by the team of the Eye Clinic of the University Hospital Basel, click here (only in German).